Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Hemangioma 3Breast Neoplasms 3Neoplasms 2Heart Failure 2Smoldering Multiple Myeloma 1Postoperative Nausea and Vomiting 1Pain, Postoperative 1Pain 1Ovarian Neoplasms 1Multiple Myeloma 1Hyperalgesia 1Hemangioma, Capillary 1Essential Hypertension 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Echocardiography 4sacubitril and valsartan sodium hydrate drug combination 3Standard of Care 3Nutrition Assessment 3Exercise 3Electrocardiography 3Carvedilol 3dapagliflozin 2Surveys and Questionnaires 2Spironolactone 2Rituximab 2Lenalidomide 2Ivabradine 2Control Groups 2Blood Specimen Collection 2Atorvastatin 2Adrenergic beta-Antagonists 2ziprasidone 1pertuzumab 1pegfilgrastim 1obinutuzumab 1nicotinamide-beta-riboside 1empagliflozin 1candesartan 1acalabrutinib 1Zolpidem 1Watchful Waiting 1Warfarin 1Vincristine 1Vecuronium Bromide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Heart Failure × Adrenergic beta-Antagonists × Clear all
NCT02818517 2022-02-02

Evaluation and Management of Cardio Toxicity in Oncologic Patients

Tel-Aviv Sourasky Medical Center

Recruiting
1,000 enrolled

Heart Failure

NCT02907021 2020-10-09

SCHOLAR

Population Health Research Institute

Phase 1 Completed
20 enrolled
Breast

Breast Neoplasms, Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon âš¡